Evaluation of Magnetic Resonance Thermometry Precision during MR guided Hyperthermia Treatment of Patients with Soft Tissue Sarcoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033833

Enrollment

Registered

2024-03-12

Start date

2023-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C49

Interventions

Group 1: patients with soft tissue sarcoma of the pelvic region or lower extremities who received a systemic chemotherapy in combination with deep regional hyperthermia, and were treated with the hybr

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with soft-tissue sarcoma in the pelvic or thigh region treated with MR guided hyperthermia

Exclusion criteria

Exclusion criteria: no, retrospective analysis

Design outcomes

Primary

Measure	Time frame
The target variable is the temperature increase which is determined with MR thermometry during hyperthermia treatment in patients with soft tissue sarcoma in the pelvis and lower extremities. The precision of the MRT temperature measurement can be quantified using data from all the patients and treatments combined.	—

Secondary

Measure	Time frame
MRT accuracy can be quantified by comparing the MR thermometry data with the temperature data from intraluminal/invasive probes in the treatments where temperature probes were applied in the target region.	—

Countries

Germany

Contacts

Public ContactMarianne Göger-Neff

LMU Klinikum

marianne.goeger@med.lmu.de004989440077741

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026